ARCHIVES

GSK’s Pazopanib Benefits Similar to Sunitinib; Sponsor Points to More Favorable Safety Profile

This article is from The Cancer Letter archive.

Vol. 36 No. 8 | August 30, 2013

Download PDF Visit The Full Archive

Related Articles

ORI Finds St. Mary’s Data Managers Falsified Data In BCPT

September 8, 1995

Congress Passes Biomedical Research Authorization, Regular Appropriations Bill; NCI Gets $1.183 Billion

October 19, 1984

Board of Scientific Advisors discussion: Are peer reviewers correctly interpreting the guidelines?

March 19, 2004

Advisors Voted For Provenge Approval Despite Fundamental Flaws In Trials.

April 13, 2007

NCI R01 Payline Falls To 12th Percentile In Fifth Year Of No-Growth Budgets.

March 7, 2008

Caribbean Conference Reports Incidence Differences With U.S.

August 22, 1986